| ALZECURE PHARMA AB |
| Schweden |
| Gesundheit |
| SE0010133785 / A2N951 |
| AC6 (Frankfurt) |
| FRA:AC6, ETR:AC6, AC6:GR |
| - |
| https://www.alzecurepharm.. |
|
Alzecure Pharma AB is a biopharmaceutical company engaged in the development of therapies for neurological disorders. Its primary focus is on generating innovative treatments that address significant unmet needs in areas such as Alzheimer's disease, ..
>Volltext.. |
| 17.85 Mio. EUR |
| 13.47 Mio. EUR |
| - |
| -4.57 Mio. EUR |
| -4.46 Mio. EUR |
| -0.04 EUR |
| 0.24 Mio. EUR |
| 4.72 Mio. EUR |
| -3.24 Mio. EUR |
| 2.14 |
| - |
| -35.13% |
| - |
| - |
| - |
| - |
| ALZECURE |
| 05.04.26 |
|